Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |